ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein...
51 insider purchases on record · latest filing 2026-08-07.
Insiders have also filed 1 sale transaction at PMN.